Track the Onesource Specialty Pharma Limited stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Onesource Specialty Pharma Limited has recorded 16 insider filings. Market capitalisation: €185.7bn. The latest transaction was filed on 4 February 2026 (Purchase). Among the most active insiders: Tenshi Pharmaceuticals Private Limited. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
€4m
6 ops.
Buy Volume
€170m
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Onesource Specialty Pharma Limited Buy (bullish), based on 4 analysts. Average price target: ₹2,056.00.
10Σ signal
Buys €4m€170m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,311 of 29,063 companies
33.2
score / 100
Value
29
Quality
37
FCF yld-3.0%
Earn yld-0.4%
EV/EBITDA·
ROE-1.3%
Gross mgn69%
Net mgn-5.2%
Debt/EBITDA4.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ ₹1,487.1475100.0% of flowEquity SharesSEBI:0eac7c3d08edd1b5ceabce2b77472eb77eae8465
16 of 16 declarations
Acerca de Onesource Specialty Pharma Limited
Onesource Specialty Pharma Limited es una empresa enfocada en el sector de la salud y farmacéutico. Se especializa en el desarrollo y distribución de medicamentos especializados.